Works matching IS 1386341X AND DT 2015 AND VI 18 AND IP 3
Results: 20
Octreotide LAR treatment of acromegaly in 'real life': long-term outcome at a tertiary care center.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 290, doi. 10.1007/s11102-014-0570-0
- By:
- Publication type:
- Article
Effects of low dose versus high dose human growth hormone on body composition and lipids in adults with GH deficiency: a meta-analysis of placebo-controlled randomized trials.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 297, doi. 10.1007/s11102-014-0571-z
- By:
- Publication type:
- Article
KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 306, doi. 10.1007/s11102-014-0572-y
- By:
- Publication type:
- Article
We stand upon the shoulders of giants!
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 417, doi. 10.1007/s11102-014-0573-x
- By:
- Publication type:
- Article
Update on prognostic factors in acromegaly: Is a risk score possible?
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 431, doi. 10.1007/s11102-014-0574-9
- By:
- Publication type:
- Article
Insulin resistance, metabolic syndrome and chronic low grade inflammation in Sheehan's syndrome on standard replacement therapy: a case control study.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 312, doi. 10.1007/s11102-014-0575-8
- By:
- Publication type:
- Article
Importance of cannulated prolactin test in the definition of hyperprolactinaemia.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 319, doi. 10.1007/s11102-014-0576-7
- By:
- Publication type:
- Article
Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 326, doi. 10.1007/s11102-014-0578-5
- By:
- Publication type:
- Article
Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 335, doi. 10.1007/s11102-014-0579-4
- By:
- Publication type:
- Article
The prevalence and associated factors of colorectal neoplasms in acromegaly: a single center based study.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 343, doi. 10.1007/s11102-014-0580-y
- By:
- Publication type:
- Article
Bilateral cerebral infarction in the setting of pituitary apoplexy: a case presentation and literature review.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 352, doi. 10.1007/s11102-014-0581-x
- By:
- Publication type:
- Article
Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 359, doi. 10.1007/s11102-014-0582-9
- By:
- Publication type:
- Article
Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 366, doi. 10.1007/s11102-014-0583-8
- By:
- Publication type:
- Article
Gamma knife radiosurgery for Cushing's disease and Nelson's syndrome.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 376, doi. 10.1007/s11102-014-0584-7
- By:
- Publication type:
- Article
Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 385, doi. 10.1007/s11102-014-0585-6
- By:
- Publication type:
- Article
Extracapsular en bloc resection in pituitary adenoma surgery.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 397, doi. 10.1007/s11102-014-0587-4
- By:
- Publication type:
- Article
Giant prolactinomas: clinical manifestations and outcomes of 16 Arab cases.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 405, doi. 10.1007/s11102-014-0588-3
- By:
- Publication type:
- Article
Evaluation of survivin splice variants in pituitary tumors.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 410, doi. 10.1007/s11102-014-0590-9
- By:
- Publication type:
- Article
Erratum to: Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
Incidence of Cushing's syndrome and Cushing's disease in commercially-insured patients <65 years old in the United States.
- Published in:
- Pituitary, 2015, v. 18, n. 3, p. 283, doi. 10.1007/s11102-014-0569-6
- By:
- Publication type:
- Article